Award

Purchase of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Consumables

  • NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)

F15: Voluntary ex ante transparency notice

Notice identifier: 2024/S 000-032102

Procurement identifier (OCID): ocds-h6vhtk-04a66f

Published 7 October 2024, 3:38pm



Section one: Contracting authority/entity

one.1) Name and addresses

NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)

Woodland House, Maes YCoed Road

Cardiff

CF15 7QZ

Contact

Jessie Beavan

Email

jessie.beavan@wales.nhs.uk

Country

United Kingdom

NUTS code

UK - United Kingdom

Internet address(es)

Main address

http://nwssp.nhs.wales/ourservices/procurement-services/

Buyer's address

https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221

one.4) Type of the contracting authority

Regional or local authority

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Purchase of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Consumables

two.1.2) Main CPV code

  • 33140000 - Medical consumables

two.1.3) Type of contract

Supplies

two.1.4) Short description

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is a type of hyperthermia therapy used in combination with surgery in the treatment of advanced abdominal cancers. The Cardiff and Vale University Health Board completed an open tender procedure in 2022, to purchase the consumables, kit and maintenance required to complete HIPEC and has since received additional funding to continue the treatment process over the next 2 years. Without the repurchase of consumables, the service cannot continue, subsequently, the Health Board would need to send patients elsewhere for treatment.

two.1.6) Information about lots

This contract is divided into lots: No

two.1.7) Total value of the procurement (excluding VAT)

Value excluding VAT: £56,000

two.2) Description

two.2.2) Additional CPV code(s)

  • 33140000 - Medical consumables

two.2.3) Place of performance

NUTS codes
  • UKL22 - Cardiff and Vale of Glamorgan

two.2.4) Description of the procurement

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is a type of hyperthermia therapy used in combination with surgery in the treatment of advanced abdominal cancers. The Cardiff and Vale University Health Board completed an open tender procedure in 2022, to purchase the consumables, kit and maintenance required to complete HIPEC and has since received additional funding to continue the treatment process over the next 2 years. Without the repurchase of consumables, the service cannot continue, subsequently, the Health Board would need to send patients elsewhere for treatment.

The original tender was awarded to Gamida LTD after the trial of multiple different supplier’s kit and consumables. The kit was purchased soon after from Gamida LTD. Now that the Health Board has received further funding for HIPEC treatment, there is a need to repurchase the necessary consumables from Gamida LTD to continue the service and treat patients, utilising the current equipment purchased as a result of the tender process.

For a continuity of service, the Health Board are direct awarding to Gamida LTD to continue providing the necessary treatment and service to patients.

two.2.11) Information about options

Options: No

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Award of a contract without prior publication of a call for competition in the cases listed below

  • The procurement falls outside the scope of application of the regulations

Explanation:

The original tender was awarded to Gamida LTD after the trial of multiple different supplier’s kit and consumables. The kit was purchased soon after from Gamida LTD. Now that the Health Board has received further funding for HIPEC treatment, there is a need to repurchase the necessary consumables from Gamida LTD to continue the service and treat patients, utilising the current equipment purchased as a result of the tender process.

For a continuity of service, the Health Board are direct awarding to Gamida LTD to continue providing the necessary treatment and service to patients.

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes


Section five. Award of contract/concession

A contract/lot is awarded: Yes

five.2) Award of contract/concession

five.2.1) Date of conclusion of the contract

30 September 2024

five.2.2) Information about tenders

The contract has been awarded to a group of economic operators: No

five.2.3) Name and address of the contractor/concessionaire

GAMIDA SA

31 rue des alouettes

Eaubonne

95600

Country

France

NUTS code
  • FR10 - Ile-de-France
The contractor/concessionaire is an SME

No

five.2.4) Information on value of contract/lot/concession (excluding VAT)

Total value of the contract/lot/concession: £56,000


Section six. Complementary information

six.3) Additional information

NOTE: To register your interest in this notice and obtain any additional information please visit the Sell2Wales Web Site at https://www.sell2wales.gov.wales/Search/Search_Switch.aspx?ID=144888.

(WA Ref:144888)

six.4) Procedures for review

six.4.1) Review body

High Court

Royal Courts of Justice, The Strand

London

WC2A 2LL

Telephone

+44 2079477501

Country

United Kingdom